Similar Blog Posts

CEO/CSO Tamaki to Speak at Keio University’s Advanced Research and Education Symposium, January 27

CEO/CSO Tamaki to Speak at Keio University’s Advanced Research and Education Symposium, January 27

Read more
CEO/CSO玉木が慶應義塾大学先端研究教育連携シンポジウムに登壇, January 27

CEO/CSO玉木が慶應義塾大学先端研究教育連携シンポジウムに登壇, January 27

Read more
MOLCURE signs joint research agreement with Teijin Pharma to develop antibody drugs using AI-driven drug discovery platform technology, January 9

MOLCURE signs joint research agreement with Teijin Pharma to develop antibody drugs using AI-driven drug discovery platform technology, January 9

Read more
帝人ファーマとAI創薬プラットフォーム技術を活用した抗体医薬品の創製に関する共同研究契約を締結, January 9

帝人ファーマとAI創薬プラットフォーム技術を活用した抗体医薬品の創製に関する共同研究契約を締結, January 9

Read more